Success Stories: NAILG Obtains EB-1A Approval Following NOID for Expert in Biostatistics and Data Science
Client’s Testimonial:
“I am very satisfied with your services. Please keep it up!”
On October 24th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Lecturer and Data Analyst in the Field of Statistics (Approval Notice).
General Field: Statistics
Position at the Time of Case Filing: Senior Lecturer and Data Analyst
Country of Origin: Ethiopia
Country of Residence at the Time of Filing: South Africa
Approval Notice Date: October 24th, 2025
Processing Time: 2 months, 5 days (Premium Processing Requested)
Case Summary:
NAILG successfully obtained an EB-1A (Alien of Extraordinary Ability) approval for a distinguished expert in statistics specializing in biostatistics, data visualization, and global health research. Despite receiving a Notice of Intent to Deny (NOID) after filing in August 2025, our team effectively demonstrated our client’s extraordinary ability and sustained international acclaim, leading to final approval in October 2025.
Recognized Authority in Biostatistics and Data Visualization
With a Ph.D. in statistics, our client has built a career at the intersection of statistical innovation and global health. His pioneering research in biostatistics, data visualization, and global health has generated novel methodologies that have become foundational references for advancing healthcare analytics and improving disease modeling worldwide. Our client’s research on COVID-19 mortality risk modeling, HIV progression, and food insecurity has provided actionable insights for public health response, contributing directly to more equitable healthcare practices.
As one expert observed, “By identifying comorbidities and risk profiles, [Client] provided a transparent framework that informed patient care and resource prioritization protocols in clinical and public health settings. Moreover, his work created an evidence-based rationale for triaging high-risk patients during health emergencies.”
Accomplishments and Research Impact
Our client’s record of achievement is both extensive and internationally recognized:
- Authored 36 peer-reviewed journal articles (12 first-authored) and 3 first-authored conference abstracts published in leading scientific journals.
- His research has been cited 1,517 times, placing him among the top 1% most highly cited authors in statistics over the past decade.
- Performed at least 26 peer reviews for top-ranked journals.
- Served as a Ph.D. dissertation committee member, further validating his recognized authority in the field.
Overcoming the NOID and Securing EB-1A Approval
When USCIS issued a Notice of Intent to Deny (NOID) in September 2025, NAILG immediately presented a robust and evidence-backed response emphasizing our client’s extraordinary qualifications under the Kazarian framework. We effectively demonstrated that he met multiple EB-1A regulatory criteria, including judging the work of others, original contributions of major significance, authorship in top-tier journals, and leadership roles for distinguished organizations. Our legal arguments successfully established his sustained acclaim and pivotal influence in global health research, resulting in approval just weeks later.
EB-1A Approval and Outlook
The client’s EB-1A approval stands as a testament to his exceptional impact on biostatistics and global health, as well as NAILG’s meticulous case preparation and advocacy in response to the NOID. His work continues to shape how complex health data is interpreted and applied to save lives, guide resource distribution, and inform public policy.
NAILG is proud to have represented him in this successful EB-1A petition and looks forward to his continued contributions to the advancement of public health and statistical innovation in the United States.